Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 191-200 of 481 for sleep

Edit search filters
  1. PrecISE (Precision Interventions For Severe And/or Exacerbation-Prone Asthma) Network Study

    Scottsdale/Phoenix, AZ

  2. Mesenchymal Stem Cell Therapy For Lung Rejection

    Jacksonville, FL

  3. MARK 1A Series: Percutaneous Microwave Ablation For Patients With Lung Tumor(s)

    Rochester, MN

  4. A Study Comparing Sublobar Resection Versus Stereotactic Ablative Radiotherapy For Lung Cancer

    Rochester, MN

  5. A Trial To Compare Nintedanib With Placebo For Patients With Scleroderma Related Lung Fibrosis

    Rochester, MN

  6. PKCι & MTOR Inhibition With Auranofin+Sirolimus For Squamous Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  7. A Study To Evaluate Protective Ventilation With High Versus Low PEEP During One-lung Ventilation For Thoracic Surgery

    Jacksonville, FL

  8. A Study Of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy For Advanced Non-Small Cell Lung Cancer (MK-3475-495)

    Jacksonville, FL, Rochester, MN

  9. A Study Of Afatinib Treatment For Patients With Epidermal Growth Factor Receptor Mutation Positive Non-Small Cell Lung Cancer, Who Are Age 70 Or Older

    Scottsdale/Phoenix, AZ

  10. A Study Of LJPC-501 In Patients With Catecholamine-Resistant Hypotension

    Rochester, MN

.

Mayo Clinic Footer